CN1772750A - (R)-N-(3-fluoro-4-morpholine phenyl)-oxazolone-5-methyl alcohol preparation process - Google Patents

(R)-N-(3-fluoro-4-morpholine phenyl)-oxazolone-5-methyl alcohol preparation process Download PDF

Info

Publication number
CN1772750A
CN1772750A CN 200510048548 CN200510048548A CN1772750A CN 1772750 A CN1772750 A CN 1772750A CN 200510048548 CN200510048548 CN 200510048548 CN 200510048548 A CN200510048548 A CN 200510048548A CN 1772750 A CN1772750 A CN 1772750A
Authority
CN
China
Prior art keywords
fluoro
morpholine
oxazolone
methyl alcohol
phenyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN 200510048548
Other languages
Chinese (zh)
Inventor
黄强
李华
牛柏林
班春兰
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Zhengzhou University
Original Assignee
Zhengzhou University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zhengzhou University filed Critical Zhengzhou University
Priority to CN 200510048548 priority Critical patent/CN1772750A/en
Publication of CN1772750A publication Critical patent/CN1772750A/en
Pending legal-status Critical Current

Links

Landscapes

  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)

Abstract

The present invention discloses the preparation process of Linezolid, and the preparation process includes the following steps: condensation of morpholine and 3, 4-difluoro nitrobenzene; reduction into 3-fluoro-4-morpholinyl aniline under the catalysis of Fe, and acylation with phosgene into 3-fluoro-4-morpholinylphenyl isocyanate; cyclization with (R)-butyl glycidate to produce (R)-N-(3-fluoro-4-morpholinylphenyl)-oxazolone-5-methyl alcohol; and further conventional synthesis steps. The present invention has simple technological process, mild reaction condition, cheap catalyst and low production cost, and is favorable to industrial production.

Description

(R)-N-(3-氟-4-吗啉苯基)-噁唑酮-5-甲基醇制备工艺(R)-N-(3-fluoro-4-morpholine phenyl)-oxazolone-5-methyl alcohol preparation process

(一)技术领域(1) Technical field

本发明涉及药物中间体的制备新工艺,具体为抗菌类药物Linezolid合成过程中所涉及的重要中间体(R)-N-(3-氟-4-吗啉苯基)-噁唑酮-5-甲基醇的合成新工艺。The present invention relates to a new process for the preparation of pharmaceutical intermediates, specifically an important intermediate (R)-N-(3-fluoro-4-morpholine phenyl)-oxazolone-5 involved in the synthesis of antibacterial drug Linezolid - A new process for the synthesis of methyl alcohol.

(二)背景技术(2) Background technology

(R)-N-(3-氟-4-吗啉苯基)-噁唑酮-5-甲基醇(以下称之为噁唑酮)是新一代抗菌药(R)-N-(3-氟-4-吗啉苯基)-2-氧代-噁唑-5-甲基-乙酰胺(以下称之为Linezolid即利奈唑烷)在合成过程中所涉及到的重要中间体。(R)-N-(3-fluoro-4-morpholine phenyl)-oxazolone-5-methyl alcohol (hereinafter referred to as oxazolone) is a new generation of antibacterial drugs (R)-N-(3 -Fluoro-4-morpholine phenyl)-2-oxo-oxazole-5-methyl-acetamide (hereinafter referred to as Linezolid or Linezolid) is an important intermediate involved in the synthesis process.

Linezolid是一种最新的全合成化学抗菌药物,化学名称为(R)-N-(3-氟-4-吗啉苯基)-2-氧代-噁唑-5-甲基-乙酰胺。它是20世纪90年代由pharmacia∝Upjohn公司,首先研制成功并于2000年在美国已批准上市的。Linezolid是第一个应用于临床的新型噁唑烷酮类抗菌药,该药结构和作用机制独特,不易产生耐药性。具有广谱抗菌、毒性小、高度有效之特点。特别对其它抗菌物不能有效拟制的细菌,如甲氧西林耐药金葡萄(MRSA),耐青霉素肺炎球菌,耐万古霉素肠球菌等有良好的抗菌效果。Linezolid is a newest fully synthetic chemical antibacterial drug with the chemical name (R)-N-(3-fluoro-4-morpholine phenyl)-2-oxo-oxazole-5-methyl-acetamide. It was first successfully developed by pharmacia∝Upjohn in the 1990s and approved for marketing in the United States in 2000. Linezolid is the first new type of oxazolidinone antibacterial drug used in clinical practice. It has a unique structure and mechanism of action and is not prone to drug resistance. It has the characteristics of broad-spectrum antibacterial, low toxicity and high effectiveness. Especially, it has good antibacterial effect on bacteria that other antibacterial substances cannot effectively suppress, such as methicillin-resistant aureus (MRSA), penicillin-resistant pneumococcus, and vancomycin-resistant enterococcus.

Linezolid从早期来抑制革兰氏阳性菌蛋白质的合成。作为第一类阻止早期革兰氏阳性菌蛋白质合成的抗生素。Linezolid有着广阔的发展前景,Linezolid用于治疗耐多种药物的G+菌和结核杆菌感染。对耐万古酶素肠球菌(VRE)引起的菌血病,耐甲氧西林金黄色葡萄球菌(MRSA)引起的肺炎、皮肤感染,以及耐青霉素肺炎链球菌(PRSP)引起的菌血病有良好的疗效,被认为是一种极具应用价值的新型抗菌剂。最近国内也开始了合成研究该药物抗菌谱广,抗菌活性强,细菌对这种药物与其它类合成药之间无交叉耐药性,而且还未发现病菌对此类药物的抗药性,因此,可以判定Linezolid将会在近年内被推广,并且会成为抗生素类的主打药物。目前世界上许多国家正在大力进行噁唑烷酮类药物的研究,因此研究(R)-N-(3-氟-吗啉苯基)-噁唑酮-5-甲基醇合成的新工艺对我国噁唑烷类药物开发具有推动作用。Linezolid inhibits protein synthesis in Gram-positive bacteria from an early age. As the first class of antibiotics to prevent protein synthesis in early Gram-positive bacteria. Linezolid has broad prospects for development, and Linezolid is used to treat multidrug-resistant Gram + bacteria and Mycobacterium tuberculosis infections. Good for bacteremia caused by vancomycin-resistant enterococci (VRE), pneumonia and skin infections caused by methicillin-resistant Staphylococcus aureus (MRSA), and bacteremia caused by penicillin-resistant Streptococcus pneumoniae (PRSP) It is considered to be a new type of antibacterial agent with great application value. Recently, domestic researches on the synthesis of this drug have broad antibacterial spectrum and strong antibacterial activity. Bacteria have no cross-resistance between this drug and other types of synthetic drugs, and no bacteria have been found to be resistant to this type of drug. Therefore, It can be determined that Linezolid will be promoted in recent years and will become the main drug of antibiotics. Many countries in the world are vigorously carrying out the research of oxazolidinones at present, so the new technique of researching (R)-N-(3-fluoro-morpholine phenyl)-oxazolone-5-methylalcohol is beneficial to The development of oxazolidine drugs in my country plays a role in promoting.

(R)-N-(3-氟-4-吗啉苯基)-噁唑酮-5-甲基醇化合物,是最终产物Linezolid即利奈唑烷合成过程中的重要中间体。目前最典型的合成方法也就是WO 95/07071专利中公开的Linezolid的合成方法的前4步方法。Linezolid的合成方法如下所述:(R)-N-(3-fluoro-4-morpholine phenyl)-oxazolone-5-methyl alcohol compound is an important intermediate in the synthesis process of the final product Linezolid, that is, linezolid. The most typical synthetic method is the first 4 steps of the synthetic method of Linezolid disclosed in WO 95/07071 patent. The synthesis method of Linezolid is as follows:

(1)3-氟-4-吗啉苯基的合成;(1) Synthesis of 3-fluoro-4-morpholine phenyl;

(2)3-氟-4-吗啉苯胺的合成;(2) Synthesis of 3-fluoro-4-morpholine aniline;

(3)N-苄氧羰基-3-氟-4-吗啉基苯胺的合成;(3) Synthesis of N-benzyloxycarbonyl-3-fluoro-4-morpholinoaniline;

(4)(R)-N-[3-(3-氟-4-吗啉)苯基-2-氧代-5-噁唑]甲基醇的合成;(4) Synthesis of (R)-N-[3-(3-fluoro-4-morpholine)phenyl-2-oxo-5-oxazole]methyl alcohol;

(5)(R)-[3-(3‘-氟-4’-吗啉)苯基-2-氧代-5-噁唑烷基]甲醇甲磺酸酯的合成;(5) Synthesis of (R)-[3-(3'-fluoro-4'-morpholine)phenyl-2-oxo-5-oxazolidinyl]methanol mesylate;

(6)(R)-[3-(3‘-氟-4’-吗啉)苯基-2-氧代-5-噁唑烷基]甲基叠氮化合物的合成;(6) Synthesis of (R)-[3-(3'-fluoro-4'-morpholine)phenyl-2-oxo-5-oxazolidinyl]methyl azide;

(7)Linezolid的合成。(7) Synthesis of Linezolid.

反应式如下:The reaction formula is as follows:

Figure A20051004854800041
Figure A20051004854800041

吗啉  3,4-二氟硝基苯  3-氟-4-吗啉硝基苯  3-氟-4-吗啉苯胺Morpholine 3,4-Difluoronitrobenzene 3-fluoro-4-morpholinenitrobenzene 3-fluoro-4-morpholineaniline

Figure A20051004854800042
Figure A20051004854800042

N-苄甲酸酯基-3-氟-4-吗啉苯胺N-Benzoate-3-fluoro-4-morpholine aniline

Figure A20051004854800043
Figure A20051004854800043

(R)-N-(3-氯-4-吗啉苯基)-噁唑酮甲基醇(R)-N-(3-Chloro-4-morpholinephenyl)-oxazolone methyl alcohol

(R)-N-(3-氯-4-吗啉苯基)-噁唑酮基甲基叠氮(R)-N-(3-chloro-4-morpholine phenyl)-oxazolone methyl azide

(R)-N-(3-氯-4-吗啉苯基)-噁唑酮基-甲基乙酰胺(R)-N-(3-Chloro-4-morpholinephenyl)-oxazolone-methylacetamide

该合成方法的主要缺陷在于:The main drawback of this synthesis method is:

1.原工艺路线较长,从工艺起始原料到最终的产品共经过七步反应,其中各步骤都要经过分离,提纯,干燥等工序。1. The original process route is long, and there are seven steps of reaction from the starting material to the final product, and each step must go through separation, purification, drying and other processes.

2.原工艺原料难得,价格也较高。2. The raw materials of the original process are rare and the price is relatively high.

3.原工艺中加氢还原是以10%的钯碳为催化剂,价格较高;环化反应要求温度为-78℃,反应条件严格。3. The hydrogenation reduction in the original process uses 10% palladium carbon as a catalyst, and the price is relatively high; the cyclization reaction requires a temperature of -78°C and strict reaction conditions.

(三)发明内容(3) Contents of the invention

缩上所述开发高效、成本低的工艺路线是非常有必要的,本发明的目的在于提供合(R)-N-(3-氟-4-吗啉苯基)-噁唑酮-5-甲基醇的制备新工艺。现将改进后的工艺路线简述如下:It is very necessary to develop a highly efficient and low-cost process route. The purpose of the present invention is to provide (R)-N-(3-fluoro-4-morpholine phenyl)-oxazolone-5- A new process for the preparation of methyl alcohol. Now the improved process route is briefly described as follows:

以吗啉和3,4-二氟硝基苯为原料,在有机相中反应缩合成3-氟-4-吗啉硝基苯;Using morpholine and 3,4-difluoronitrobenzene as raw materials, react and condense into 3-fluoro-4-morpholine nitrobenzene in the organic phase;

以铁粉为催化剂,以水为供氢剂在酸性环境中,用所述缩合生成的3-氟-4-吗啉硝基苯还原成3-氟-4-吗啉苯胺;Using iron powder as a catalyst and water as a hydrogen donor in an acidic environment, using the 3-fluoro-4-morpholine nitrobenzene generated by the condensation to reduce 3-fluoro-4-morpholine aniline;

以光气为酰化剂,将上述还原得到3-氟-4-吗啉苯胺酰化,得到3-氟-4-吗啉苯异腈酸酯;Using phosgene as an acylating agent, acylate the above reduction to obtain 3-fluoro-4-morpholine anilide to obtain 3-fluoro-4-morpholine benzene isocyanate;

在无水情况下,将光气酰化形成的3-氟-4-吗啉苯异腈酸酯与(R)-缩水甘油丁酸酯在有机相反应生成(R)-N-(3-氟-4-吗啉苯基)-2氧代-噁唑酮-5-甲基丁酸酯;In the absence of water, the 3-fluoro-4-morpholine benzene isocyanate formed by the acylation of phosgene reacts with (R)-glycidyl butyrate in the organic phase to generate (R)-N-(3- Fluoro-4-morpholinephenyl)-2oxo-oxazolone-5-methylbutyrate;

以上述酯化—环化生成的(R)-N-(3-氟-4-吗啉苯基)-2氧代-噁唑酮-5-甲基丁酸酯,在常温下和甲醇钠反应生成(R)-N-(3-氟-4-吗啉苯基)-噁唑酮-5-甲基醇。The (R)-N-(3-fluoro-4-morpholine phenyl)-2 oxo-oxazolone-5-methylbutyrate generated by the above-mentioned esterification-cyclization was mixed with sodium methylate at room temperature The reaction produces (R)-N-(3-fluoro-4-morpholinephenyl)-oxazolone-5-methyl alcohol.

由于(R)-N-(3-氟-吗啉苯基)-噁唑酮-5-甲基醇单独存在没有什么意义,其主要作用就是作为合成Linezolid的中间体。其上所述也可以作为合成Linezolid的前期工艺,以后的工艺步骤与公知技术的一致。Since (R)-N-(3-fluoro-morpholine phenyl)-oxazolone-5-methylalcohol has no meaning in itself, its main function is as an intermediate for the synthesis of Linezolid. The above description can also be used as a pre-process for synthesizing Linezolid, and the subsequent process steps are consistent with known techniques.

本发明的优越性在于:改进后的工艺工序简单,反应温和。在选用催化剂方面,普遍使用如碳酸钠、铁粉等易得、且价格便宜的催化剂。避免使用价格昂贵的原料如苄基氯甲酸酯。因而大大降低了生产成本,更有利于工艺生产。The invention has the advantages that the improved process is simple and the reaction is mild. In terms of catalyst selection, readily available and cheap catalysts such as sodium carbonate and iron powder are widely used. Avoid expensive starting materials such as benzyl chloroformate. Therefore, the production cost is greatly reduced, and it is more conducive to the process production.

(四)具体实施方式(4) Specific implementation methods

(1)缩合:以吗啉和3,4-二氟硝基苯为原料,以Na2CO3为催化剂反应生成3-氟-4-吗啉硝基苯;(1) Condensation: using morpholine and 3,4-difluoronitrobenzene as raw materials, using Na 2 CO 3 as a catalyst to generate 3-fluoro-4-morpholine nitrobenzene;

(2)还原——酰化:3-氟-4-吗啉硝基苯在催化剂铁粉和以水为供氢剂的作用下还原成3-氟-4-吗啉苯胺;(2) Reduction—acylation: 3-fluoro-4-morpholine nitrobenzene is reduced to 3-fluoro-4-morpholine aniline under the action of catalyst iron powder and water as a hydrogen donor;

(3)3-氟-4-吗啉苯胺,在无水的情况下然后经光气酰化得3-氟-4-吗啉苯异腈酸酯:(3) 3-fluoro-4-morpholine aniline, in the case of anhydrous then through phosgene acylation to get 3-fluoro-4-morpholine benzene isocyanate:

(4)腈酸酯化(缩合):3-氟-4-吗啉苯异腈酸酯与(R)-缩水甘油丁酸酯在无水的情况下环化生成(R)-N-(3-氟-4-吗啉苯基)-噁唑酮-5-甲基丁酸酯;(4) Nitrilation (condensation): 3-fluoro-4-morpholine benzene isocyanate and (R)-glycidyl butyrate are cyclized to generate (R)-N-( 3-fluoro-4-morpholine phenyl)-oxazolone-5-methylbutyrate;

(5)环化等:(R)-N-(3-氟-4-吗啉苯基)-噁唑酮-5-甲基丁酸酯常温下和甲醇钠反应生成(R)-N-(3-氟-吗啉苯基)-噁唑酮-5-甲基醇。从该步反应向下合成步骤和原来的合成路线一样。最终可以得到Linezolid利奈唑烷。(5) Cyclization, etc.: (R)-N-(3-fluoro-4-morpholine phenyl)-oxazolone-5-methylbutyrate reacts with sodium methoxide at room temperature to form (R)-N- (3-Fluoro-morpholinephenyl)-oxazolone-5-methylalcohol. The downward synthetic steps from this step reaction are the same as the original synthetic route. Eventually Linezolid is available.

Figure A20051004854800072
Figure A20051004854800072

主要实验仪器:KDM调温电热套,电动搅拌机,数显调节仪,接触调压器,恒温磁力搅拌器,电子天平,真空干燥箱,真空泵,超级恒温水浴,旋转式蒸发仪,紫外可见分光光度计,红外分光光度计,核磁共振仪,元素分析仪,数字熔点仪。Main experimental instruments: KDM thermostat electric heating mantle, electric mixer, digital display regulator, contact pressure regulator, constant temperature magnetic stirrer, electronic balance, vacuum drying oven, vacuum pump, super constant temperature water bath, rotary evaporator, UV-visible spectrophotometer meter, infrared spectrophotometer, nuclear magnetic resonance instrument, elemental analyzer, digital melting point instrument.

实验药品:吗啉,3.4-二氟硝基苯(天津市科密欧化学试剂开发中心),四氯甲烷,20%发烟浓硫酸,甲苯,(R)-缩水甘油丁酸酯,溴化锂,无水碳酸钠,亚硫酸氢钠,氯化铵,盐酸均为分析纯。Experimental drugs: morpholine, 3.4-difluoronitrobenzene (Tianjin Kemiou Chemical Reagent Development Center), tetrachloromethane, 20% fuming concentrated sulfuric acid, toluene, (R)-glycidyl butyrate, lithium bromide, Anhydrous sodium carbonate, sodium bisulfite, ammonium chloride, and hydrochloric acid are all analytically pure.

实施例:Example:

(1)合成3-氟-4-吗啉硝基苯:(1) Synthesis of 3-fluoro-4-morpholine nitrobenzene:

将20ml 3,4-二氟硝基苯(0.18mol)溶于50mL C2H5OH中并在溶液中加入0.5g无水Na2CO3。将19ml(0.20mol)吗啉用50mL C2H5OH稀释后加入以上溶液,在回流状态下(t=79℃)反应6h,反应液为微橙黄色。冷却后过滤,得黄色固体,将母液蒸馏,得到少量橙色固体,固相合并,用120ml水洗涤两次,真空干燥50min(真空度0.95,t=85℃)得黄色固体33.1g。将以上固体用乙酸乙酯重结晶后,放于黑暗处保存,以防变色,收率为81.11%,在显微镜在观察为黄色片状透明晶体,在数字熔点测定仪测定熔点为mp111.7-112.5℃。(文献值mp 111-112℃)20 ml of 3,4-difluoronitrobenzene (0.18 mol) was dissolved in 50 mL of C 2 H 5 OH and 0.5 g of anhydrous Na 2 CO 3 was added to the solution. Dilute 19ml (0.20mol) of morpholine with 50mL of C 2 H 5 OH and add to the above solution, and react for 6h under reflux (t=79°C), the reaction solution is slightly orange-yellow. After cooling, it was filtered to obtain a yellow solid. The mother liquor was distilled to obtain a small amount of orange solid. The solid phases were combined, washed twice with 120 ml of water, and vacuum-dried for 50 min (vacuum degree 0.95, t=85° C.) to obtain 33.1 g of a yellow solid. After the above solid was recrystallized with ethyl acetate, it was stored in a dark place to prevent discoloration. The yield was 81.11%. It was observed under a microscope as a yellow flaky transparent crystal, and its melting point was mp111.7- 112.5°C. (Literature value mp 111-112°C)

收率:91.11%Yield: 91.11%

(2)合成3-氟-4-吗啉苯胺(2) Synthesis of 3-fluoro-4-morpholine aniline

在200ml水中加入10g还原铁粉,0.5gNH4Cl,4ml浓HCl(36%)加热至98℃,加入5g3-氟-4-吗啉硝基苯,反应1小时后,再加入3g3-氟-4-吗啉硝基苯,1小时后第三次加入2g,补加1.5g铁粉和少许氯化铵,控温在98℃,搅拌状态下反应3小时,调PH=9,再加入1.5活性碳脱色,10min后停止搅拌,进行热过滤,抽滤所用布氏漏斗先预热,防止产品在漏斗上结晶,抽滤瓶内加入少许抗氧化剂NaHSO3。抽滤所得母液冷却至室温,有大量白色结晶出现,用100ml乙酸乙酯萃取收集有机相,再用50ml乙酸乙酯萃取两次,合并有机相,用无水碳酸钠干燥后真空蒸馏,得6.8g白色固体,收率78.84%,熔点120-121℃,将产品密封干燥后保存,防止吸水及氧化。Add 10g of reduced iron powder, 0.5g of NH 4 Cl, 4ml of concentrated HCl (36%) in 200ml of water and heat to 98°C, add 5g of 3-fluoro-4-morpholine nitrobenzene, react for 1 hour, then add 3g of 3-fluoro- 4-Morpholine nitrobenzene, add 2g for the third time after 1 hour, add 1.5g of iron powder and a little ammonium chloride, control the temperature at 98°C, react for 3 hours under stirring, adjust the pH to 9, then add 1.5 Decolorize with activated carbon, stop stirring after 10 minutes, and carry out hot filtration. The Buchner funnel used for suction filtration is preheated first to prevent the product from crystallizing on the funnel. Add a little antioxidant NaHSO 3 into the suction filtration bottle. Suction filtration gained mother liquor is cooled to room temperature, and a large amount of white crystals appear, extract and collect organic phase with 100ml ethyl acetate, then extract twice with 50ml ethyl acetate, combine organic phase, vacuum distill after drying with anhydrous sodium carbonate, obtain 6.8 g white solid, yield 78.84%, melting point 120-121 ° C, the product is sealed and dried to prevent water absorption and oxidation.

3-氟-4-吗啉苯胺的收率78.84%。The yield of 3-fluoro-4-morpholine aniline was 78.84%.

(3)合成3-氟-4-吗啉苯异腈酸酯:(3) Synthesis of 3-fluoro-4-morpholine benzene isocyanate:

向30ml甲苯溶液中通入光气30min,使溶液中光气饱和。分四批加入3-氟-4-吗啉苯胺,每次加入3-氟-4-吗啉苯胺的量为0.5g,在搅拌状态下通入光气,每批低温(0-5℃)下反应1h,反应液为乳白色,然后缓慢升温至70℃反应4-5h,停止通入光气。通入氮气30min赶走反应器中剩余的光气,停止加热。真空蒸馏得棕色液体0.873g,收率62.11%。(粗品)Introduce phosgene into 30ml of toluene solution for 30min to saturate the solution with phosgene. Add 3-fluoro-4-morpholine aniline in four batches, the amount of 3-fluoro-4-morpholine aniline added each time is 0.5g, pass through phosgene under stirring state, each batch of low temperature (0-5°C) The reaction was carried out at low temperature for 1 hour, and the reaction liquid was milky white, then the temperature was raised slowly to 70° C. for 4-5 hours, and the introduction of phosgene was stopped. Nitrogen was introduced for 30 minutes to drive away the remaining phosgene in the reactor, and the heating was stopped. Vacuum distillation gave 0.873 g of a brown liquid, with a yield of 62.11%. (Crude)

3-氟-4-吗啉苯异腈酸酯的收率62.11%The yield of 3-fluoro-4-morpholine benzene isocyanate is 62.11%

(4)合成(R)-N-(3-氟-吗啉苯基)-噁唑酮-5-甲基醇(4) Synthesis of (R)-N-(3-fluoro-morpholine phenyl)-oxazolone-5-methyl alcohol

将0.1gLiBr和0.03g三丁基氧化磷加入到5ml甲苯中,回流1h,然后冷却到30-40℃。先加入0.25g3-氟-4-吗啉苯异腈酸酯,然后加入0.144gR-缩水甘油丁酸酯和5ml的甲苯。在80℃下反应7h,停止反应。真空蒸馏除去甲苯。干燥、储存,直接用于下一步反应。Add 0.1g LiBr and 0.03g tributylphosphine oxide to 5ml toluene, reflux for 1h, and then cool to 30-40°C. First add 0.25 g of 3-fluoro-4-morpholine benzene isocyanate, then add 0.144 g of R-glycidyl butyrate and 5 ml of toluene. React at 80°C for 7h and stop the reaction. Toluene was distilled off in vacuo. Dry, store, and use directly in the next reaction.

将10毫升甲醇钠溶于20毫升甲醇中,将0.5g(R)-N-(3-氟-吗啉苯基)-噁唑酮-5-甲基丁酸酯加入到甲醇钠溶液中,室温搅拌2小时,停止反应,滴加1-2滴水除去剩余的甲醇钠。过滤得亮紫色固体,用体积比为1∶1的乙酸乙酯和正己烷洗涤得白色固体。干燥,称重。Dissolve 10 ml of sodium methoxide in 20 ml of methanol, add 0.5 g of (R)-N-(3-fluoro-morpholine phenyl)-oxazolone-5-methylbutyrate into the sodium methoxide solution, Stir at room temperature for 2 hours, stop the reaction, add 1-2 drops of water to remove the remaining sodium methoxide. A bright purple solid was obtained by filtration, and washed with ethyl acetate and n-hexane at a volume ratio of 1:1 to obtain a white solid. Dry and weigh.

原工艺路线有以下特点:The original process route has the following characteristics:

(1)原工艺路线中3-氟-4-吗啉硝基苯的制备是以二异丙基乙基胺为催化剂,回流状态下反应。二异丙基乙基胺用量大,3,4-二氟吗啉硝基苯与催化剂二异丙基乙基胺几乎1∶1(moL)。二异丙基乙基胺价格较Na2CO3高出很多。(1) The preparation of 3-fluoro-4-morpholine nitrobenzene in the original process route takes diisopropylethylamine as a catalyst and reacts under the reflux state. The amount of diisopropylethylamine is large, and the ratio of 3,4-difluoromorpholine nitrobenzene to the catalyst diisopropylethylamine is almost 1:1 (moL). The price of diisopropylethylamine is much higher than that of Na 2 CO 3 .

(2)原工艺路线中原工艺路线中3-氟-4-吗啉硝基苯的还原是以钯碳(pd/c)为催化剂,以甲酸胺为供氢剂的,其成本较高。(2) In the original process route, the reduction of 3-fluoro-4-morpholine nitrobenzene in the original process route is based on palladium carbon (pd/c) as a catalyst and ammonium formate as a hydrogen donor, and its cost is relatively high.

(3)原工艺路线中N-苄氧羰基-3-氟-4-吗啉基苯胺的合成,使用氯甲酸苄酯。氯甲酸苄酯价格很高,且不易购得。(3) The synthesis of N-benzyloxycarbonyl-3-fluoro-4-morpholinoaniline in the original process route uses benzyl chloroformate. Benzyl chloroformate is expensive and not readily available.

(4)原工艺路线中(R)-N-[3-(3-氟-4-吗啉)苯基-2-氧代-5-噁唑]甲基醇的合成,反应温度-78℃,反应条件苛刻工业上不宜实现。(4) Synthesis of (R)-N-[3-(3-fluoro-4-morpholine)phenyl-2-oxo-5-oxazole]methyl alcohol in the original process route, reaction temperature -78°C , the harsh reaction conditions are unsuitable for industrial realization.

新工艺路线特点:Features of the new process route:

(1)新工艺路线中3-氟-4-吗啉硝基苯的制备是以Na2CO3为催化剂。Na2CO3价格较低,使用量少,反应的成本降低了很多。(1) The preparation of 3-fluoro-4-morpholine nitrobenzene in the new process route uses Na 2 CO 3 as a catalyst. The price of Na 2 CO 3 is low, and the usage amount is small, so the cost of the reaction is greatly reduced.

(2)新工艺路线中3-氟-4-吗啉硝基苯的还原是以Fe为催化剂,还原铁粉作催化剂,以水为供氢剂,大大降低了反应的成本,但反应后铁泥要进行处理。(2) The reduction of 3-fluoro-4-morpholine nitrobenzene in the new process route takes Fe as a catalyst, reduced iron powder as a catalyst, and water as a hydrogen donor, which greatly reduces the cost of the reaction, but after the reaction, the iron Mud needs to be processed.

(3)新工艺路线中改变了工艺路线,取消了原工艺路线中N-苄氧羰基-3-氟-4-吗啉基苯胺的合成,改成了经光气酰化得3-氟-4-吗啉苯异腈酸酯,再与(R)-缩水甘油丁酸酯环化生成(R)-N-(3-氟-4-吗啉苯基)-噁唑酮-5-甲基丁酸酯。本工艺路线中的环合得到噁唑酮的反应条件是在甲苯回流温度(t=80℃),相比之下,本工艺合成要易控制得多(原有工艺的环化得到噁唑酮环是-78℃条件下反应)。光气与氯甲酸苄酯相比价格要低数十倍。(3) In the new process route, the process route has been changed, the synthesis of N-benzyloxycarbonyl-3-fluoro-4-morpholinoaniline in the original process route has been canceled, and the synthesis of 3-fluoro-4-morpholinylaniline has been changed to phosgene acylation to obtain 3-fluoro- 4-morpholine benzene isocyanate, and then cyclized with (R)-glycidyl butyrate to generate (R)-N-(3-fluoro-4-morpholine phenyl)-oxazolone-5-methanol butyrate. The reaction condition that the cyclization in this operational route obtains oxazolone is at toluene reflux temperature (t=80 ℃), by contrast, this technique synthesis is much easier to control (the cyclization of original technique obtains oxazolone The ring is reacted at -78°C). Phosgene is dozens of times cheaper than benzyl chloroformate.

本工艺路线中酰氯反应参加反应的光气是剧毒气体。操作一定要注意安全。而且酰氯反应要求无水反应,所得产品在进下步反应时也要求无水,以防分解。The phosgene that the acid chloride reaction participates in the reaction in this process route is a highly toxic gas. Operation must pay attention to safety. And the acid chloride reaction requires anhydrous reaction, and the product obtained also requires anhydrous when proceeding to the next step reaction, in order to prevent decomposition.

(4)新工艺路线中得到的linezolid中间体R-N-[3-(3-氟-4-吗啉)苯-2-氧-5-噁唑酮]甲基丁酸酯,此丁酸酯不必分离提纯,直接可进行下步反应,在常温条件下与甲醇钠反应生成白色固态(R)-N-[3-(3-氟-4-吗啉)苯-2-氧-5-噁唑酮]甲醇。(4) The linezolid intermediate R-N-[3-(3-fluoro-4-morpholine) benzene-2-oxo-5-oxazolone] methyl butyrate obtained in the new process route, this butyrate does not have to Separation and purification, the next step reaction can be carried out directly, and the white solid (R)-N-[3-(3-fluoro-4-morpholine) benzene-2-oxo-5-oxazole can be produced by reacting with sodium methoxide at room temperature Ketone] Methanol.

(5)与原有工艺路线相比,本工艺路线合成步骤增加了一步,但整体的反应条件温和,反应成本低。新工艺合成路线中反应温和,所用催化剂价格低廉,成本低。(5) Compared with the original process route, the synthesis step of this process route has increased by one step, but the overall reaction conditions are mild and the reaction cost is low. In the synthesis route of the new process, the reaction is mild, and the catalyst used is low in price and low in cost.

各步骤实验结果:The experimental results of each step:

(1)3-氟-4-吗啉硝基苯:(1) 3-fluoro-4-morpholine nitrobenzene:

状态:黄色晶体。熔点:111.7-112.5℃。反应收率:91.11%。结构鉴定(红外,核磁,紫外)。State: yellow crystal. Melting point: 111.7-112.5°C. Reaction yield: 91.11%. Structural identification (IR, NMR, UV).

(2)3-氟-4-吗啉硝苯胺:(2) 3-Fluoro-4-morpholine Nitidine:

状态:白色晶体。熔点:120-121℃。反应收率:78.84%。薄层分析:Rf=0.43(层析液为v/v=2/3的环己烷/乙酸乙酯溶液)。结构鉴定(红外,核磁,紫外):State: white crystal. Melting point: 120-121°C. Reaction yield: 78.84%. TLC analysis: Rf=0.43 (chromatographic solution is cyclohexane/ethyl acetate solution with v/v=2/3). Structural identification (IR, NMR, UV):

(3)3-氟-4-吗啉苯异腈酸酯:(3) 3-fluoro-4-morpholine benzene isocyanate:

反应收率:62.11%。薄层分析:Rf=0.92(层析液为v/v=2/1.5的环己烷/乙酸乙酯溶液)。Reaction yield: 62.11%. TLC analysis: Rf=0.92 (chromatographic solution is cyclohexane/ethyl acetate solution of v/v=2/1.5).

(4)(R)-N-(3-氟-吗啉苯基)-噁唑酮-5-甲基醇:(4) (R)-N-(3-fluoro-morpholine phenyl)-oxazolone-5-methyl alcohol:

状态:白色晶体或浅黄色晶体。熔点:110℃。反应收率:53.1%。State: white crystal or light yellow crystal. Melting point: 110°C. Reaction yield: 53.1%.

Claims (5)

1.(R)-N-(3-氟-4-吗啉苯基)-噁唑酮-5-甲基醇制备工艺,其特征在于由下述步骤完成:1. (R)-N-(3-fluoro-4-morpholine phenyl)-oxazolone-5-methyl alcohol preparation process is characterized in that it is completed by the following steps: 以吗啉和3,4-二氟硝基苯为原料,在有机相中反应缩合成3-氟-4-吗啉硝基苯;Using morpholine and 3,4-difluoronitrobenzene as raw materials, react and condense into 3-fluoro-4-morpholine nitrobenzene in the organic phase; 以铁粉为催化剂,以水为供氢剂在酸性环境中,用所述缩合生成的3-氟-4-吗啉硝基苯还原成3-氟-4-吗啉苯胺;Using iron powder as a catalyst and water as a hydrogen donor in an acidic environment, using the 3-fluoro-4-morpholine nitrobenzene generated by the condensation to reduce 3-fluoro-4-morpholine aniline; 以光气为酰化剂,将上述还原得到3-氟-4-吗啉苯胺酰化,得到3-氟-4-吗啉苯异腈酸酯;Using phosgene as an acylating agent, acylate the above reduction to obtain 3-fluoro-4-morpholine anilide to obtain 3-fluoro-4-morpholine benzene isocyanate; 在无水情况下,将光气酰化形成的3-氟-4-吗啉苯异腈酸酯与(R)-缩水甘油丁酸酯在有机相反应生成(R)-N-(3-氟-4-吗啉苯基)-2氧代-噁唑酮-5-甲基丁酸酯;In the absence of water, the 3-fluoro-4-morpholine benzene isocyanate formed by the acylation of phosgene reacts with (R)-glycidyl butyrate in the organic phase to generate (R)-N-(3- Fluoro-4-morpholinephenyl)-2oxo-oxazolone-5-methylbutyrate; 以上述酯化—环化生成的(R)-N-(3-氟-4-吗啉苯基)-2氧代-噁唑酮-5-甲基丁酸酯,在常温下和甲醇钠反应生成(R)-N-(3-氟-4-吗啉苯基)-噁唑酮-5-甲基醇。The (R)-N-(3-fluoro-4-morpholine phenyl)-2 oxo-oxazolone-5-methylbutyrate generated by the above-mentioned esterification-cyclization was mixed with sodium methylate at room temperature The reaction produces (R)-N-(3-fluoro-4-morpholinephenyl)-oxazolone-5-methyl alcohol. 2.根据权利要求1所述的(R)-N-(3-氟-4-吗啉苯基)-噁唑酮-5-甲基醇制备工艺,其特征在于所述吗啉与3,4-二氟硝基苯缩合反应中所用的催化剂为Na2CO32. (R)-N-(3-fluoro-4-morpholine phenyl)-oxazolone-5-methyl alcohol preparation process according to claim 1, is characterized in that described morpholine and 3, The catalyst used in the condensation reaction of 4-difluoronitrobenzene is Na 2 CO 3 . 3.根据权利要求1所述的(R)-N-(3-氟-4-吗啉苯基)-噁唑酮-5-甲基醇制备工艺,其特征在于所述的酸性环境为浓盐酸与NH4Cl形成的。3. (R)-N-(3-fluoro-4-morpholine phenyl)-oxazolone-5-methyl alcohol preparation process according to claim 1 is characterized in that described acidic environment is concentrated Hydrochloric acid and NH 4 Cl formation. 4.根据权利要求1所述的(R)-N-(3-氟-4-吗啉苯基)-噁唑酮-5-甲基醇制备工艺,其特征在于3-氟-4-吗啉硝基苯形成3-氟-4-吗啉苯胺反应过程中,3-氟-4-吗啉硝基苯是分批加入的。4. (R)-N-(3-fluoro-4-morpholine phenyl)-oxazolone-5-methyl alcohol preparation process according to claim 1 is characterized in that 3-fluoro-4-morpholine During the reaction process of forming 3-fluoro-4-morpholine aniline from morpholine nitrobenzene, 3-fluoro-4-morpholine nitrobenzene is added in batches. 5.根据权利要求1所述的(R)-N-(3-氟-4-吗啉苯基)-噁唑酮-5-甲基醇制备工艺,其特征在于光气酰化反应过程中光气是分批通入的。5. (R)-N-(3-fluoro-4-morpholine phenyl)-oxazolone-5-methyl alcohol preparation process according to claim 1 is characterized in that during the phosgene acylation reaction process Phosgene is fed in batches.
CN 200510048548 2005-11-15 2005-11-15 (R)-N-(3-fluoro-4-morpholine phenyl)-oxazolone-5-methyl alcohol preparation process Pending CN1772750A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN 200510048548 CN1772750A (en) 2005-11-15 2005-11-15 (R)-N-(3-fluoro-4-morpholine phenyl)-oxazolone-5-methyl alcohol preparation process

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN 200510048548 CN1772750A (en) 2005-11-15 2005-11-15 (R)-N-(3-fluoro-4-morpholine phenyl)-oxazolone-5-methyl alcohol preparation process

Publications (1)

Publication Number Publication Date
CN1772750A true CN1772750A (en) 2006-05-17

Family

ID=36759910

Family Applications (1)

Application Number Title Priority Date Filing Date
CN 200510048548 Pending CN1772750A (en) 2005-11-15 2005-11-15 (R)-N-(3-fluoro-4-morpholine phenyl)-oxazolone-5-methyl alcohol preparation process

Country Status (1)

Country Link
CN (1) CN1772750A (en)

Cited By (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009032294A3 (en) * 2007-09-06 2009-05-28 Teva Pharma Processes for the preparation of a linezolid intermediate, linezolid hydroxide
WO2010081404A1 (en) 2009-01-13 2010-07-22 联化科技股份有限公司 Method for preparing linezolid and intermediates thereof
CN101659645B (en) * 2009-09-14 2011-08-10 苏州敬业医药化工有限公司 Method for preparing 3-fluorine-4 morpholinyl phenylamine
CN101638392B (en) * 2009-08-24 2012-05-16 浙江工业大学 A kind of preparation method of linezolid
CN102753537A (en) * 2010-02-10 2012-10-24 桑多斯股份公司 Method for the preparation of rivaroxaban
WO2013001096A1 (en) 2011-06-30 2013-01-03 Dsm Ip Assets B.V. Silicone-containing monomer
WO2013120448A1 (en) 2012-02-15 2013-08-22 浙江海正药业股份有限公司 Method for preparing linezolid intermediate
US9012631B2 (en) 2011-06-15 2015-04-21 Yabang Pharmaceutical Co., Ltd 1,3-oxazolidine-2-one-like compound, preparation method and uses thereof
WO2021031533A1 (en) 2019-08-20 2021-02-25 杭州迪克科技有限公司 Method for synthesizing n-substituted phenyl-5-hydroxymethyl-2-oxazolidinone

Cited By (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009032294A3 (en) * 2007-09-06 2009-05-28 Teva Pharma Processes for the preparation of a linezolid intermediate, linezolid hydroxide
US8658789B2 (en) 2009-01-13 2014-02-25 Lianhe Chemical Technology Co., Ltd. Method for preparing linezolid and intermediates thereof
WO2010081404A1 (en) 2009-01-13 2010-07-22 联化科技股份有限公司 Method for preparing linezolid and intermediates thereof
CN101638392B (en) * 2009-08-24 2012-05-16 浙江工业大学 A kind of preparation method of linezolid
CN101659645B (en) * 2009-09-14 2011-08-10 苏州敬业医药化工有限公司 Method for preparing 3-fluorine-4 morpholinyl phenylamine
CN102753537A (en) * 2010-02-10 2012-10-24 桑多斯股份公司 Method for the preparation of rivaroxaban
CN102753537B (en) * 2010-02-10 2015-09-02 桑多斯股份公司 Prepare the method for razaxaban
US9012631B2 (en) 2011-06-15 2015-04-21 Yabang Pharmaceutical Co., Ltd 1,3-oxazolidine-2-one-like compound, preparation method and uses thereof
WO2013001096A1 (en) 2011-06-30 2013-01-03 Dsm Ip Assets B.V. Silicone-containing monomer
JP2015506992A (en) * 2012-02-15 2015-03-05 浙江海正薬業股▲ふん▼有限公司Zhejiang Hisun Pharmaceutical CO.,LTD. Process for the preparation of a linezolid intermediate
WO2013120448A1 (en) 2012-02-15 2013-08-22 浙江海正药业股份有限公司 Method for preparing linezolid intermediate
US9434702B2 (en) 2012-02-15 2016-09-06 Zhejiang Hisun Pharamceutical Co., Ltd. Method for preparing linezolid intermediate
WO2021031533A1 (en) 2019-08-20 2021-02-25 杭州迪克科技有限公司 Method for synthesizing n-substituted phenyl-5-hydroxymethyl-2-oxazolidinone
US12312320B2 (en) 2019-08-20 2025-05-27 Hangzhou Dike Technologies Co., Ltd. Method for synthesizing n-substituted phenyl-5-hydroxymethyl-2-oxazolidinone

Similar Documents

Publication Publication Date Title
CN1046520C (en) Bicyclic oxazine and thiazine oxazolidinone antibacterials
CN1772750A (en) (R)-N-(3-fluoro-4-morpholine phenyl)-oxazolone-5-methyl alcohol preparation process
SK52398A3 (en) Intermediary compounds for the hemisynthesis of taxanes and preparation processes therefor
CN1927830A (en) Compound of optically pure sulfenamides and application thereof
CN1880302A (en) Method for synthesizing isorhodanate
CN101220001A (en) Synthesis of linezolid
CN101265271A (en) Method for synthesizing penem-like pharmaceutical intermediate 4AA
CN102516191B (en) Method for preparing Linezolid
EP2816039B1 (en) Method for preparing linezolid intermediate
CN115521324B (en) Preparation of a near-infrared fluorescent probe for detecting β-lactamase in drug-resistant bacteria
CN111559985A (en) Oxazolone compounds with bactericidal effect and preparation method thereof
CN1164568C (en) A kind of condensation method of salicylaldehyde and arylamine
CN112851584B (en) Non-activated beta-C (sp) in the synthesis of carboxylic acid derivatives 3 ) Method for nitrating-H bond
CN101977890A (en) Process for production of optically active fluoroamine
CN105111160B (en) Linezolid preparation method
CN1023121C (en) Crystal of hydrochloric salt of etoposide-2-dimethylamino compounds and process for preparing them
CN1037509C (en) Process for the preparation of ortho-hydroxy substituted aromatic nitriles via dehydration of the corresponding aldoximes
CN102702125B (en) Chemical synthesis method for linezolid
CN1254466C (en) Process for preparing 3,4-dihydroxy benzonitrile
CN107129440B (en) A kind of total synthesis method of natural products (+)-negamycin
CN1305863C (en) Method for synthesizing (S)-isopropyl-(2-piperidine) phenyl-methylhistamine
CN112457236A (en) Preparation method of linezolid intermediate
CN1894223A (en) Process for the production of DTPA-bis anhydride
CN1575272A (en) Method for preparing 4-nitroso-substituted aromatic amine
CN1152921A (en) Pyrido [3, 2, 1-i, j ] [3, 1] benzoxazine derivatives

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication